Cholesterol lowering and cerebrospinal fluid neurotransmitters: increased levels of the anxiogenic cholecystokinin-tetrapeptide during simvastatin administration to healthy male volunteers.
Eriksson
M
M
Department of Medicine, Huddinge University Hospital, Sweden.
Eklundh
T
T
Sjöberg
S
S
Angelin
B
B
Nordin
C
C
D000328:Adult; D000924:Anticholesteremic Agents / Q000008:administration & dosage*; D002784:Cholesterol / Q000378:metabolism*; D006801:Humans; D008148:Lovastatin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008297:Male; D018377:Neurotransmitter Agents / Q000134:cerebrospinal fluid*; D012016:Reference Values; D019821:Simvastatin; D013758:Tetragastrin / Q000378:metabolism*
D000924:Anticholesteremic Agents; D018377:Neurotransmitter Agents; D013758:Tetragastrin; D002784:Cholesterol; D008148:Lovastatin; D019821:Simvastatin